Viral load of human papillomavirus and risk of CIN3 or cervical cancer

Attila T. Lorincz, Philip E. Castle, Mark E. Sherman, David R. Scott, Andrew G. Glass, Sholom Wacholder, Brenda B. Rush, Patti E. Gravitt, John E. Schussler, Mark Schiffman

Research output: Contribution to journalArticle

Abstract

Carcinogenic human papillomaviruses (HPV) are thought to be necessary for development of cervical cancer. We assessed whether higher viral loads of such viruses predicted future risk of CIN3 or cancer (CIN3+) in a cohort of 20 810 women followed up for 10 years with cytological screening. We measured the viral load for 13 types of carcinogenic HPV (relative light units normalised to 1 pg/mL HPV 16 positive controls [RLU/PC]) using Hybrid Capture 2 testing of cervicovaginal lavages obtained at enrolment. Results were stratified into four groups (RLU/PC 1 to

Original languageEnglish (US)
Pages (from-to)228-229
Number of pages2
JournalThe Lancet
Volume360
Issue number9328
DOIs
Publication statusPublished - Jul 20 2002

    Fingerprint

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Lorincz, A. T., Castle, P. E., Sherman, M. E., Scott, D. R., Glass, A. G., Wacholder, S., ... Schiffman, M. (2002). Viral load of human papillomavirus and risk of CIN3 or cervical cancer. The Lancet, 360(9328), 228-229. https://doi.org/10.1016/S0140-6736(02)09463-1